Medicare Enrolled
Dr. Sooraj Shah
Adult Congenital Heart Disease Physician · Costa Mesa, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Sooraj Shah is an adult congenital heart disease physician in Costa Mesa, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 1,780 Medicare services across 1,102 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shah received a total of $13,780 from 35 pharmaceutical and/or device companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in adult congenital heart disease physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 14% volume in CA
$13,780 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,780
Medicare services
Top 14% in CA for adult congenital heart disease physician
1,102
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
446 | $111 | $299 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
280 | $102 | $258 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
142 | $157 | $430 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $75 | $245 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
103 | $148 | $464 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
99 | $164 | $534 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
86 | $12 | $50 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
80 | $39 | $120 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
55 | $181 | $413 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
45 | $7 | $25 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
33 | $415 | $1,200 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
33 | $56 | $226 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
32 | $1 | $40 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $68 | $201 |
| Cardiac catheterization | 27 | $174 | $1,048 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
23 | $180 | $513 |
| New patient office visit, complex (60-74 min) | 22 | $193 | $467 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
19 | $19 | $200 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
18 | $798 | $1,267 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
18 | $77 | $276 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
18 | $117 | $294 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
16 | $13 | $31 |
| Stent placement and plaque removal in one vessel A procedure to clear plaque and blood clots from a single blood vessel, followed by the insertion of a stent and/or balloon dilation to keep the vessel open. |
15 | $539 | $1,007 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
12 | $481 | $1,004 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.4% high complexity
11.5% medium
78.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,780
Total received (2018-2024)
Avg $1,969/year across 7 years
Top 31% in CA for adult congenital heart disease physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
209
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,320 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$460 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,190
2023
$1,469
2022
$1,166
2021
$1,734
2020
$2,646
2019
$3,242
2018
$2,332
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$256
Inari Medical, Inc.
$180
ShockWave Medical, Inc
$168
Reflow Medical Inc
$136
AstraZeneca Pharmaceuticals LP
$113
Novartis Pharmaceuticals Corporation
$80
Kiniksa Pharmaceuticals International, plc
$58
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
ABIOMED
$52
Amgen Inc.
$44
Edwards Lifesciences Corporation
$32
E.R. Squibb & Sons, L.L.C.
$18
Top 3 companies account for 50.8% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$2,565
Boston Scientific Corporation
$2,298
BOSTON SCIENTIFIC CORPORATION
$1,191
Esperion Therapeutics, Inc.
$1,126
Cardiovascular Systems Inc.
$878
Janssen Pharmaceuticals, Inc
$807
Medtronic, Inc.
$757
Philips Electronics North America Corporation
$650
AstraZeneca Pharmaceuticals LP
$627
Amgen Inc.
$270
Novo Nordisk Inc
$234
CVRx, Inc.
$211
Novartis Pharmaceuticals Corporation
$187
Inari Medical, Inc.
$180
Bard Peripheral Vascular, Inc.
$178
E.R. Squibb & Sons, L.L.C.
$173
ShockWave Medical, Inc
$168
Edwards Lifesciences Corporation
$148
Reflow Medical Inc
$136
Amarin Pharma Inc.
$136
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$125
Stereotaxis Inc
$125
Merck Sharp & Dohme LLC
$121
ABIOMED
$77
Boehringer Ingelheim Pharmaceuticals, Inc.
$77
BARD PERIPHERAL VASCULAR, INC.
$59
Kiniksa Pharmaceuticals International, plc
$58
PFIZER INC.
$42
CathWorks, Inc.
$32
Biosense Webster, Inc.
$31
Kestra Medical Technology Services, Inc.
$30
Kiniksa Pharmaceuticals, Ltd.
$24
Alnylam Pharmaceuticals Inc.
$21
Astellas Pharma US Inc
$21
MEDICOMP INC
$18
Top 3 companies account for 43.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (9266) ELCA · AMPLATZER Occluders · AMVUTTRA · Arcalyst · Assure WCD · BREZTRI · BRILINTA · Barostim Neo System · CAMZYOS · COMET · COREVALVE EVOLUT R · COROFLOW · CardioMEMS HF System · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ENTRESTO · FARXIGA · FFRANGIO · FLOWTRIEVER CATHETER · GALLANT · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · GENERAL ULTRASOUND · GENERAL - ATHERECTOMY · GENERAL - STENTS · GENERAL - STRUCTURAL HEART · GENERAL - THERAPIES · GENERAL ATHERECTOMY · GENERAL STENTS · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · GENERAL ULTRASOUND · GENERAL VASCULAR ACCESS · GUIDEZILLA · HAWKONE · HeartMate 3 Left Ventricular Dev · IGT D Coronary · Impella · JARDIANCE · JOT DX · LEQVIO · LEXISCAN · LUTONIX · LifeVest · Mitra Clip system · MitraClip System · NEXLIZET · NUVISION ICE CATHETER · Niobe · OPTICROSS · Ozempic · PASCAL · Peripheral Orbital Atherectomy System · RESONATE · ROTABLATOR · Repatha · Resolute · S · SAPIEN 3 Ultra RESILIA · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TELEPATCH CARDIAC MONITOR · TELESCOPE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Telescope · VERQUVO · VYNDAQEL · Vascepa · Vascular Closure Devices · WATCHMAN · WOLVERINE · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Adult congenital heart disease physicians within 10 mi
1
Per 100K population
0.0
County median income
$113,702
Nearest hospital
COLLEGE HOSPITAL COSTA MESA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shah performed 446 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $13,780 from 35 companies across 209 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other adult congenital heart disease physicians in Costa Mesa?
Dr. Shah's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Adult Congenital Heart Disease Physicians in Costa Mesa
Browse adult congenital heart disease physicians in Costa Mesa ranked by procedure volume and transparency data.
Highest volume
Top Adult Congenital Heart Disease Physicians in CA
Adult congenital heart disease physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult Congenital Heart Disease Physicians in CA
Which CA adult congenital heart disease physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology